Background This study is to identify, summarise and synthesise literature on the causes of
the evidence to practice gap for complex interventions in primary care. Design This study is …

Background There is considerable interest in the effectiveness of financial incentives in the
delivery of health care. Incentives may be used in an attempt to increase the use of evidence …

Introduction: There is continued unmet medical need for new medicines across countries
especially for cancer, immunological diseases, and orphan diseases. However, there are …

Background The successful diffusion of new drugs is crucial for both pharmaceutical
companies and patients—and of wider stakeholder concern, including for the funding of …

Aim: the aim of this article was to evaluate the influence of different demand-side measures
to enhance the prescribing of generics in ambulatory care based on cross-national …

Background Implementation and uptake of novel and cost-effective medicines can improve
patient health outcomes and healthcare efficiency. However, the uptake of new medicines …

The rapid rise in pharmaceutical costs in France has been driven by new technologies and
the growing prevalence of chronic diseases as well as considerable prescribing freedom …

It is a challenge to improve public health within limited resources. Pharmaceutical policy
making is a greater challenge due to conflicting interests between key stakeholder groups …

Early switch (ES) from intravenous (IV) to oral antibiotic therapy programmes is increasingly
included as a component of hospital antimicrobial stewardship initiatives that aim to optimize …

The clinical, public health and economic implications of antimicrobial resistance present a
major threat to future healthcare. Antimicrobial use is a major driver of resistance, and …